Psiquiatria
M-A | Dose necessária de drogas antipsicóticas para prevenção de recaídas em pacientes com esquizofrenia estável.
20 Ago, 2021 | 12:19hExamination of Dosing of Antipsychotic Drugs for Relapse Prevention in Patients With Stable Schizophrenia: A Meta-analysis – JAMA Psychiatry (gratuito por tempo limitado)
Comentários no Twitter
Crucial literature review on optimal antipsychotic dosing for long term maintenance in #Schizophrenia.
Conclusion: Seek Goldilocks "just right"- definitely not high because of bad side effects, but not so low as to risk relapse.
Often easier said than done. https://t.co/RBBPBMzn9D
— Allen Frances (@AllenFrancesMD) August 20, 2021
Doses higher than 5mg/day risperidone equivalent are not more effective for relapse prevention than lower doses in #schizophrenia. But caution is required at the lower end of the dose-response curve where relapse risk disproportionally increases https://t.co/kQcnuRtzYU
— JAMA Psychiatry (@JAMAPsych) August 19, 2021
Conforme tem aumentado o uso de estimulantes, especialistas veem paralelos preocupantes com a crise de opioides.
19 Ago, 2021 | 12:09hNove em cada 10 crianças com transtorno do déficit de atenção com hiperatividade (TDAH) pode experimentar sintomas ao entrarem na idade adulta.
19 Ago, 2021 | 12:07hNine in Ten Children With ADHD May Experience Symptoms Into Young Adulthood – Psychiatric News Alert
Estudo original: Variable Patterns of Remission From ADHD in the Multimodal Treatment Study of ADHD – The American Journal of Psychiatry
[Preprint] Impacto da pandemia de COVID-19 sobre o desenvolvimento cognitivo na primeira infância: achados iniciais de um estudo observacional longitudinal sobre a saúde infantil.
16 Ago, 2021 | 12:01h
Comentário no Twitter (fio – clique para saber mais)
Preprint on the development of children born before and during the pandemic in the US.
"We find that children born during the pandemic have significantly reduced verbal, motor, and overall cognitive performance compared to children born pre-pandemic."
1/https://t.co/NInexSUDAi— Prof Francois Balloux (@BallouxFrancois) August 15, 2021
Opinião | Um chamado para a revisão do diagnóstico do transtorno desafiador de oposição – diagnósticos são para ajudar, não para causar danos.
16 Ago, 2021 | 11:42hA Call to Revise the Diagnosis of Oppositional Defiant Disorder—Diagnoses Are for Helping, Not Harming – JAMA Psychiatry (gratuito por tempo limitado)
Comentário no Twitter
Can giving someone a diagnosis (more accurately, a diagnostic label) cause harm? Undoubtedly; an example is discussed in this article https://t.co/13RysG9Yxa In rehabilitation, the term 'functional disorder' often stigmatises, & many labels generate unfair expectations in others
— Derick Wade (@derickwaderehab) August 14, 2021
Diretriz europeia sobre o tratamento da narcolepsia em adultos e crianças.
13 Ago, 2021 | 12:12hM-A | Mais de 50 efeitos de longo prazo da COVID-19.
11 Ago, 2021 | 10:57hConteúdos relacionados:
Cohort study: Risk factors for long covid in previously hospitalized children.
Viewpoint: The road to addressing Long Covid.
Review: Long covid—mechanisms, risk factors, and management.
Review: Symptoms, complications and management of long COVID.
Studies elucidate poorly understood long COVID.
Long Covid: Half of young adults with COVID-19 have persistent symptoms 6 months after, study finds.
[Preprint] Long Covid: Third of people infected have long term symptoms.
Almost 25% of COVID-19 patients develop long-lasting symptoms, according to a new report.
Perspective | The four most urgent questions about long COVID.
Systematic review: Frequency, signs and symptoms, and criteria adopted for long COVID-19.
Report: 376,000 people in UK have had long Covid symptoms for at least a year.
One third of patients hospitalized with COVID-19 have lung changes after a year
Perspective | They Tested Negative for Covid. Still, They Have Long Covid Symptoms.
Cohort study: One in ten have long-term effects 8 months following mild COVID-19
Long Covid Implications for the workplace
Long Covid in the UK – More than a million affected in February, survey suggests
Covid-19: Middle aged women face greater risk of debilitating long term symptoms
Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers”
Review | Post-acute COVID-19 syndrome
Long Covid | Four-month clinical status of a cohort of patients after hospitalization for COVID-19
Perspective | Long Covid isn’t as unique as we thought
Attributes and predictors of long COVID
WHO Report: Preparing for Long COVID 2021
Long Covid: Sequelae in adults at 6 Months after COVID-19 infection
How many people get ‘long COVID’ – and who is most at risk?
Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline
Patients, clinicians seek answers to the mystery of ‘Long COVID’
Long Covid: 6-month consequences of COVID-19 in patients discharged from hospital
NICE Guideline: Managing the long-term effects of COVID-19
Comentário no Twitter
Nuestro estudio sobre Covid 🦠Persistente o de Largo recorrido se ha publicado finalmente en @SciReports
👉https://t.co/ATFO5QO3kF pic.twitter.com/qwBikXyqll— Sonia Villapol (@svillapol) August 10, 2021
Novas ferramentas da OMS para a inclusão de pessoas com demência na sociedade.
11 Ago, 2021 | 10:39hNew WHO toolkit promotes inclusion of people with dementia in society – World Health Organization
Ver Diretriz: Towards a dementia inclusive society: WHO toolkit for dementia-friendly initiatives (DFIs) – World Health Organization
Comentário no Twitter (fio – clique para saber mais)
🆕 toolkit to promote a #dementia-inclusive society launched. It will helps countries raise public awareness and understanding of dementia to support people living with dementia to remain in, and be a significant part of, their communities.
👉 https://t.co/blpDQHUSWM pic.twitter.com/D5MIM5jdlr
— World Health Organization (WHO) (@WHO) August 10, 2021
M-A | Problemas de saúde mental em crianças e jovens dobraram durante a COVID-19.
10 Ago, 2021 | 12:49hComentário: Child and youth mental health problems have doubled during COVID-19 – The Conversation
Estudo original: Global Prevalence of Depressive and Anxiety Symptoms in Children and Adolescents During COVID-19: A Meta-analysis – JAMA Pediatrics
Editorial: Addressing the Global Crisis of Child and Adolescent Mental Health – JAMA Pediatrics
Conteúdos relacionados:
More data on the harmful effects of the COVID-19 pandemic on the mental health of adolescents.
COVID has caused ‘mass trauma,’ worsening mental health globally.
COVID’s mental-health toll: how scientists are tracking a surge in depression
WHO: COVID-19 disrupting mental health services in most countries
Comentário no Twitter (fio – clique para saber mais)
Many are rightfully sounding the alarm to a youth #mentalhealth crisis. Our meta-analysis of 29 studies w >80,000 youth worldwide in @JAMAPediatrics, shows 1 in 4 youth had elevated depression or anxiety during #COVID19. A thread 🧵 https://t.co/etIdZTHnme
— Dr. Sheri Madigan (she/her) (@sherimadigan) August 9, 2021
Perspectiva | Experiência de fora da Academia: redução de antidepressivos.
9 Ago, 2021 | 11:06hExpertise from outside the Academy: tapering off antidepressants – The Mental Elf
Conteúdos relacionados:
A method for tapering antipsychotic treatment that may minimize the risk of relapse
Systematic Review: Managing Antidepressant Discontinuation
Randomized controlled trial: preventive cognitive therapy for prevention of depressive recurrence